|
Volumn 8, Issue 12, 2003, Pages 1-11
|
Treatment of Bipolar Depression
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
CARBAMAZEPINE;
CLOZAPINE;
FLUOXETINE;
FOLIC ACID;
GABAPENTIN;
ICOSAPENTAENOIC ACID;
IMIPRAMINE;
LAMOTRIGINE;
LITHIUM;
MONOAMINE OXIDASE INHIBITOR;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
OLANZAPINE;
OMEGA 3 FATTY ACID;
PAROXETINE;
PLACEBO;
QUETIAPINE;
RISPERIDONE;
TOPIRAMATE;
TRANQUILIZER;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALPROATE SEMISODIUM;
VENLAFAXINE;
ZIPRASIDONE;
ADJUVANT THERAPY;
BIPOLAR DISORDER;
CLINICAL FEATURE;
CLINICAL TRIAL;
DEPRESSION;
DIAGNOSTIC ERROR;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
DRUG UTILIZATION;
EARLY DIAGNOSIS;
ELECTROCONVULSIVE THERAPY;
EXTRAPYRAMIDAL SYMPTOM;
FOLLOW UP;
HUMAN;
MANIA;
MORBIDITY;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
SIDE EFFECT;
SUICIDE;
SYMPTOM;
TARDIVE DYSKINESIA;
WEIGHT GAIN;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
HUMANS;
|
EID: 1642419872
PISSN: 10928529
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (0)
|